
Kick, Fight, and Scream, but Most of All Hope the Full Appeals Court (and/or the Supreme Court) Reverses
Ever since November 24, 1984, the effective date of the Drug Price Competition and Patent Term Restoration Act (aka Hatch-Waxman) which created the unique and delicate balance between innovation and safe and effective high quality generic copies of brand name products, the use of the “skinny label” has been a touchstone of that balance. Rather […]